COMPOSITION FOR PREVENTING AND TREATING CALCIUM DEFICIENCY AND OSTEOPOROSIS Russian patent published in 2025 - IPC A61K31/95 A61K31/4415 A61K31/593 A61K33/08 A61K33/30 A61K31/05 A61K31/56 A61P19/10 

FIELD: pharmaceutics.

SUBSTANCE: invention relates to pharmaceutical industry and can be used to create a medicinal product or biologically active additive for preventing and treating calcium deficiency and osteoporosis. Composition for preventing and treating calcium deficiency and osteoporosis, containing: tribasic calcium phosphate, magnesium hydroxide, cholecalciferol, pyridoxine hydrochloride, resveratrol, astragaloside IV, sodium selenate, zinc oxide and sodium tetraborate, wherein said components are in the following ratio, wt.%: tribasic calcium phosphate 70.0-90.0, magnesium hydroxide 5.0-20.0, cholecalciferol 0.006-0.04, pyridoxine hydrochloride 0.02-0.4, resveratrol 0.2-24.0, astragaloside IV 0.1-24.0, sodium selenate 0.0001-0.001, zinc oxide 0.135-1.5, sodium tetraborate 0.0003-0.002.

EFFECT: using the declared composition, the effectiveness of preventing and treating calcium deficiency and osteoporosis with no side effects and increased calcium absorption in bone tissue without a risk of excessive calcium accumulation; invention is also characterized by obtaining and using a composition of a personalized medical effect consisting in preventing bone loss in the lumbar spine and femoral neck in postmenopausal women without apparent osteoporosis; in addition, disclosed composition describes reduction of risk of joint inflammation, such as arthritis, arthrosis, and protection against complications of rheumatoid arthritis, such as periodontitis.

3 cl, 3 dwg